Mark Ray and Sarah Ernst are mentioned for advising Arbor Pharmaceuticals in its acquisition of XenoPort for a total equity value of approximately $467 million.
In the News
May 23, 2016
The Deal | Xenoport Gets Acquired, But Not by Big Public Pharma
Media Contact